CLINICAL TRIALS AND OBSERVATIONS Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenstrom macroglobulinemia

Irene M. Ghobrial; Federico Campigotto; Timothy J. Murphy; Erica N. Boswell; Ranjit Banwait; Feda Azab; Stacey Chuma; Janet Kunsman; Amanda Donovan; Farzana Masood; Diane Warren; Scott Rodig; Kenneth C. Anderson; Paul G. Richardson; Edie Weller; Jeffrey Matous

CLINICAL TRIALS AND OBSERVATIONS Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenstrom macroglobulinemia

Irene M. Ghobrial
, Federico Campigotto
, Timothy J. Murphy
, Erica N. Boswell
, Ranjit Banwait
, Feda Azab
, Stacey Chuma
, Janet Kunsman
, Amanda Donovan
, Farzana Masood
, Diane Warren
, Scott Rodig
, Kenneth C. Anderson
, Paul G. Richardson
, Edie Weller
, Jeffrey Matous

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Default journal
State	Published - Jan 1 2017

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Cite this

Ghobrial, I. M., Campigotto, F., Murphy, T. J., Boswell, E. N., Banwait, R., Azab, F., Chuma, S., Kunsman, J., Donovan, A., Masood, F., Warren, D., Rodig, S., Anderson, K. C., Richardson, P. G., Weller, E., & Matous, J. (2017). CLINICAL TRIALS AND OBSERVATIONS Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenstrom macroglobulinemia. Default journal.

Ghobrial, IM, Campigotto, F, Murphy, TJ, Boswell, EN, Banwait, R, Azab, F, Chuma, S, Kunsman, J, Donovan, A, Masood, F, Warren, D, Rodig, S, Anderson, KC, Richardson, PG, Weller, E & Matous, J 2017, 'CLINICAL TRIALS AND OBSERVATIONS Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenstrom macroglobulinemia', Default journal.

@article{6c89e102f010499aaa15d7ecc1d5c11c,

title = "CLINICAL TRIALS AND OBSERVATIONS Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenstrom macroglobulinemia",

author = "Ghobrial, \{Irene M.\} and Federico Campigotto and Murphy, \{Timothy J.\} and Boswell, \{Erica N.\} and Ranjit Banwait and Feda Azab and Stacey Chuma and Janet Kunsman and Amanda Donovan and Farzana Masood and Diane Warren and Scott Rodig and Anderson, \{Kenneth C.\} and Richardson, \{Paul G.\} and Edie Weller and Jeffrey Matous",

note = "Irene M. Ghobrial, Federico Campigotto, Timothy J. Murphy, Erica N. Boswell, Ranjit Banwait, Feda Azab, Stacey Chuma, Janet Kunsman, Amanda Donovan, Farzana Masood, Diane Warren, Scott Rodig, Kenneth C. Anderson, Paul G. Richardson, Edie Weller, Jeffrey Matous; Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenstr{\"o}m macroglobulinemia.",

year = "2017",

month = jan,

day = "1",

language = "American English",

journal = "Default journal",

}

TY - JOUR

T1 - CLINICAL TRIALS AND OBSERVATIONS Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenstrom macroglobulinemia

AU - Ghobrial, Irene M.

AU - Campigotto, Federico

AU - Murphy, Timothy J.

AU - Boswell, Erica N.

AU - Banwait, Ranjit

AU - Azab, Feda

AU - Chuma, Stacey

AU - Kunsman, Janet

AU - Donovan, Amanda

AU - Masood, Farzana

AU - Warren, Diane

AU - Rodig, Scott

AU - Anderson, Kenneth C.

AU - Richardson, Paul G.

AU - Weller, Edie

AU - Matous, Jeffrey

N1 - Irene M. Ghobrial, Federico Campigotto, Timothy J. Murphy, Erica N. Boswell, Ranjit Banwait, Feda Azab, Stacey Chuma, Janet Kunsman, Amanda Donovan, Farzana Masood, Diane Warren, Scott Rodig, Kenneth C. Anderson, Paul G. Richardson, Edie Weller, Jeffrey Matous; Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemia.

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.bloodjournal.org/content/bloodjournal/121/8/1296.full.pdf

M3 - Article

JO - Default journal

JF - Default journal

ER -

CLINICAL TRIALS AND OBSERVATIONS Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenstrom macroglobulinemia

Disciplines

Other files and links

Cite this